- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BMS-188797
Total 3139 results
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedHealthy Adult VolunteersUnited States
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Non-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisItaly, Spain, France, United Kingdom, Norway, Denmark, Germany, Hungary
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Nektar TherapeuticsCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawnResectable Biliary Tract Cancer
-
National Cancer Institute (NCI)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Carcinoma | Cervical Carcinoma, Non-SquamousTypeUnited States
-
University of ValenciaCompleted
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruiting
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesSpain, United States, France, Italy, Belgium, Germany, Poland, Czechia, Puerto Rico
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...RecruitingBeta-ThalassemiaUnited States, Turkey, Italy, Thailand, Germany, Greece
-
Bristol-Myers SquibbTerminatedPrimary Familial Dilated CardiomyopathyUnited States, Germany, Spain, United Kingdom
-
Boehringer IngelheimCompleted
-
Bristol-Myers SquibbCompletedChronic Hepatitis C Virus Infection | Chronic Hepatitis B Virus InfectionUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
PfizerBristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingHeart FailureUnited States, Canada, Italy, Poland, Spain
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, Hypertrophic ObstructiveJapan
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedA Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy ParticipantsHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedFollicular Lymphoma | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Diffuse Large B-Cell LeukemiaUnited States
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbTerminatedHealthy Volunteers | Ulcerative ColitisAustralia, Georgia, Moldova, Republic of
-
Bristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultChile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
Ronald LevyNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | B-Cell Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbCompletedType 2 DiabetesRussian Federation
-
Bristol-Myers SquibbTerminatedCarcinoma, HepatocellularChina, Korea, Republic of, Taiwan, Singapore
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Mexico, Italy, Argentina, Brazil, Chile, France, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Sarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States